The FirstTake Podcast – Jardiance delivers key win in heart failure

FirstTake on Pharma - Pharma News and Analysis Podcast

English - July 08, 2021 17:30 - 22 minutes - 15.2 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The FirstTake Podcast – Intellia presents an important gene-editing breakthrough

Next Episode: The FirstTake Podcast – Get the expert view on new Jardiance heart failure data

FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the potential role of Eli Lilly and Boehringer Ingelheim’s Jardiance as a future treatment for heart failure, the FDA’s decision to narrow labelling for Biogen’s Aduhelm, the pending departure of cancer R&D head Axel Hoos from GlaxoSmithKline and whether UCB’s bimekizumab can disrupt the psoriasis market.